| |
| |
|
| Insider
Information: |
Mccarthy Sean A. |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
634,249 |
|
|
Indirect Shares
|
93,158 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
727,407 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytomx Therapeutics, Inc. |
CTMX |
|
2024-03-26 |
634,249 |
2024-03-26 |
93,158 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-05-01 |
4 |
OE |
$0.95 |
$4,518 |
D/D |
4,781 |
6,760 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2019-09-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,500 |
7,809 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-06-26 |
4 |
OE |
$0.95 |
$4,235 |
D/D |
4,481 |
8,726 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-07-03 |
4 |
OE |
$0.95 |
$4,518 |
D/D |
4,781 |
9,026 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-08-09 |
4 |
OE |
$0.95 |
$4,518 |
D/D |
4,781 |
9,026 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2018-01-05 |
4 |
OE |
$1.13 |
$7,400 |
D/D |
6,526 |
11,169 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-10-02 |
4 |
OE |
$0.95 |
$9,036 |
D/D |
9,562 |
13,807 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-09-01 |
4 |
OE |
$0.95 |
$9,384 |
D/D |
9,930 |
14,175 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-03-20 |
4 |
OE |
$0.95 |
$13,554 |
D/D |
14,343 |
16,322 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2018-01-02 |
4 |
OE |
$1.13 |
$14,800 |
D/D |
13,052 |
17,695 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-11-01 |
4 |
OE |
$0.95 |
$13,553 |
D/D |
14,342 |
18,587 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-12-01 |
4 |
OE |
$0.95 |
$15,486 |
D/D |
14,340 |
18,983 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-08-31 |
4 |
OE |
$0.95 |
$17,724 |
D/D |
18,756 |
23,001 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-10-04 |
4 |
OE |
$0.95 |
$18,068 |
D/D |
19,120 |
23,365 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2018-03-01 |
4 |
OE |
$0.95 |
$26,825 |
D/D |
19,578 |
24,221 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2018-05-01 |
4 |
OE |
$1.57 |
$30,833 |
D/D |
19,578 |
24,221 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-02 |
4 |
AS |
$23.42 |
$305,708 |
D/D |
(13,052) |
82,063 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-03 |
4 |
AS |
$25.09 |
$50,880 |
D/D |
(2,028) |
82,063 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-05 |
4 |
AS |
$25.06 |
$112,689 |
D/D |
(4,497) |
82,063 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2018-09-04 |
4 |
AS |
$21.86 |
$285,343 |
D/D |
(13,052) |
82,063 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2018-11-30 |
4 |
A |
$11.73 |
$5,490 |
D/D |
468 |
82,531 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2019-05-31 |
4 |
A |
$8.21 |
$5,707 |
D/D |
695 |
83,226 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-03 |
4 |
OE |
$1.57 |
$3,194 |
D/D |
2,028 |
84,091 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2019-11-30 |
4 |
A |
$5.32 |
$5,747 |
D/D |
1,080 |
84,306 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2020-05-12 |
4 |
AS |
$15.00 |
$540,000 |
D/D |
(36,000) |
84,306 |
0 |
- |
|
77 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
